RAIsonance is a family of companies focused on Artificial Intelligence/Machine Learning (AI/ML)-based solutions for respiratory illness diagnostics and respiratory wellness tracking. Our mission is to deliver a meaningful, equitable, positive impact on global health with innovative, AI-powered solutions.
Our area of focus is the analysis of Forced Cough Vocalization (FCV) also known as intentional coughs. This biometric signal powers both our digital diagnostic platform, and our suite of respiratory wellness products.
RAIsonance develops and markets innovative wellness products and Software as a Medical Device (SaMD) diagnostic devices for individuals, corporations, medical professionals, and the military. We’ve developed a software-only diagnostic platform called AudibleHealth Dx that is designed to test for COVID-19, Tuberculosis, and now Influenza, currently under review by the FDA.
Our products use a non-invasive mobile app to interface with the user, making respiratory wellness tracking easy and convenient for virtually anyone with a smartphone and an internet connection.
The team at RAIsonance is made up of some of the brightest minds in the fields of respiratory wellness, medicine, software development, biotechnology, audio engineering, data science, machine learning, mobile app development, and business development.
“Our mission is to have a meaningful, positive impact on global health with these innovative, AI-powered solutions. Using a non-invasive, mobile app interface for both diagnostic testing and wellness tracking creates equity for everyone, everywhere.”
Kitty KoldingCEO & Co-FounderRAIsonance Group of Companies
Our team of software engineers, data scientists, medical professionals, audio engineers, cloud architects, regulatory experts, and product designers bring you a wealth of expertise.Let’s discuss how we can help you >